CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹37 Cr | ₹32 Cr | ₹32 Cr | ₹54 Cr | ₹77 Cr |
What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹37 Cr |
Mar2024 | ₹32 Cr |
Mar2023 | ₹32 Cr |
Mar2022 | ₹54 Cr |
Mar2021 | ₹77 Cr |
How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹37 Cr | 17.43 | |
Mar2024 | ₹32 Cr | -0.71 | |
Mar2023 | ₹32 Cr | -40.93 | |
Mar2022 | ₹54 Cr | -29.74 | |
Mar2021 | ₹77 Cr | - |
Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹17,473.4 Cr | -0.1% | 4.4% | -13.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,370.0 Cr | 0.7% | 0.4% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,087.0 Cr | -1.7% | 2% | 16.7% | Stock Analytics | |
CIPLA | ₹126,308.0 Cr | -0.9% | 5.3% | -3.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,614.0 Cr | -0.1% | 0.6% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,845.0 Cr | 4.1% | 7.6% | -3% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -0.1% |
4.4% |
-13.7% |
SENSEX | 1.1% |
1% |
-0.9% |
You may also like the below Video Courses